1. Home
  2. FINV vs EVO Comparison

FINV vs EVO Comparison

Compare FINV & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$4.96

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
EVO
Founded
2007
1993
Country
China
Germany
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FINV
EVO
Price
$4.96
$3.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$11.55
$7.00
AVG Volume (30 Days)
1.0M
250.0K
Earning Date
11-19-2025
11-05-2025
Dividend Yield
5.59%
N/A
EPS Growth
27.76
N/A
EPS
1.50
N/A
Revenue
$1,969,555,571.00
$887,396,457.00
Revenue This Year
$6.02
N/A
Revenue Next Year
N/A
$8.52
P/E Ratio
$3.45
N/A
Revenue Growth
8.81
N/A
52 Week Low
$4.70
$2.84
52 Week High
$11.08
$4.80

Technical Indicators

Market Signals
Indicator
FINV
EVO
Relative Strength Index (RSI) 38.33 66.92
Support Level $5.17 $3.10
Resistance Level $5.49 $3.69
Average True Range (ATR) 0.21 0.08
MACD 0.00 0.08
Stochastic Oscillator 3.03 89.02

Price Performance

Historical Comparison
FINV
EVO

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: